VieMed - Public Comps and Valuation Multiples

VieMed Overview

About VieMed

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

Founded

2016

HQ

Employees

1.2K+

Website

viemed.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $236M

LTM EBITDA $52.7M

EV

$269M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

VieMed Financials

VieMed has a last 12-month revenue of $236M and a last 12-month EBITDA of $52.7M.

In the most recent fiscal year, VieMed achieved revenue of $224M and an EBITDA of $42.3M.

VieMed expects next 12-month revenue of XXX and NTM EBITDA of XXX

See VieMed valuation multiples based on analyst estimates

VieMed P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$183M	$224M	XXX	XXX	XXX
Gross Profit	$84.7M	$113M	XXX	XXX	XXX
Gross Margin	46%	50%	XXX	XXX	XXX
EBITDA	$36.7M	$42.3M	XXX	XXX	XXX
EBITDA Margin	20%	19%	XXX	XXX	XXX
Net Profit	$6.2M	$10.2M	XXX	XXX	XXX
Net Margin	3%	5%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

VieMed Stock Performance

As of April 25, 2025, VieMed's stock price is $7.

VieMed has current market cap of $279M, and EV of $269M.

See VieMed trading valuation data

VieMed Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$269M	$279M	XXX	XXX	XXX	XXX	$0.32

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

VieMed Valuation Multiples

As of April 25, 2025, VieMed has market cap of $279M and EV of $269M.

VieMed's trades at 1.1x LTM EV/Revenue multiple, and 5.1x LTM EBITDA.

Analysts estimate VieMed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for VieMed and 10K+ public comps

VieMed Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$269M	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	XXX	XXX
EV/EBITDA	6.4x	XXX	XXX	XXX
P/E	24.8x	XXX	XXX	XXX
P/E/Growth	0.6x	XXX	XXX	XXX
EV/FCF	203.9x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get VieMed Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

VieMed Valuation Multiples

VieMed's NTM/LTM revenue growth is 15%

VieMed's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, VieMed's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate VieMed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for VieMed and other 10K+ public comps

VieMed Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	23%	XXX	XXX	XXX	XXX
EBITDA Margin	19%	XXX	XXX	XXX	XXX
EBITDA Growth	15%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	34%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.2M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	50%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	1%	XXX	XXX	XXX	XXX
Opex to Revenue	52%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry